Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Ocean Biomedical's total debt was $3.20M at Dec 31, 2023. For fiscal 2023 it was $3.20M, up 312.4% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $3.20M | +312.4% |
| FY2022 | Dec 31, 2022 | $776.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $3.20M | – |
| Q2 FY2023 | Jun 30, 2023 | $11.87M | – |
| Q4 FY2022 | Dec 31, 2022 | $776.00K | – |
See a number that looks wrong?